To understand which cellular processes lead to the loss of AML cells when UBE2N is inhibited, we performed a whole-genome CRISPR activation (CRISPRa) screen to identify genes that could rescue the growth potential of UBE2N-inhibited AML cells. This evidence concerns the gene UBE2N and acute myeloid leukemia.